- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 30 results
Client Alert
April 30, 2026
Reading Between the Lines: What the EU Commission's AI Anniversary Reports Signal for Non-EU Providers
Client Alert
April 24, 2026
When Regulators Build the Age Verification App: It Is Not Necessarily for the Greater Good
Client Alert
March 31, 2026
EUROPE – Council and Parliament Agree on EU Customs Reform
Client Alert
Client Alert
March 9, 2026
EUROPE – Revision of the EU General Pharmaceutical Legislation – Regulatory Protections
Client Alert
March 5, 2026
EUROPE - European Commission Adopts Proposal for the Industrial Accelerator Act – Storm in a Teacup?
Client Alert
February 5, 2026
European Union Signs EU-Mercosur Free Trade Agreement
Client Alert
December 22, 2025
EUROPE - Major Regulatory Developments in Pharmaceuticals, Biotechnology, and Medical Devices
Client Alert
November 24, 2025
The Digital Omnibus Proposal: Simplifying the EU Digital Rulebook by … adding more rules?
Client Alert
September 26, 2025
The EU’s proposal to phase out Russian gas imports: legal risks and practical challenges
Thought Leadership
September 15, 2025
Dr. Salomé Cisnal de Ugarte Re-appointed as Non-Governmental Advisor (NGA) to the EU at the International Competition Network (ICN)
Client Alert
September 5, 2025
Framework Intact, For Now: EU-US Data Flows Dodge Another Bullet